+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
ID07516522

Study of Intra-arterial and Intravenous Methylprednisolone After Successful Endovascular Thrombectomy in Adults With Anterior Circulation Large Vessel Occlusion Stroke

Led by Tang-Du Hospital · Updated on 2026-04-08

210

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of adding early intra-arterial and intravenous methylprednisolone sodium succinate treatment after successful endovascular thrombectomy in patients with acute ischemic stroke caused by large vessel blockage in the anterior brain circulation. This randomized, double-blind, placebo-controlled phase 2 trial aims to improve recovery outcomes for stroke patients treated within 24 hours of symptom onset. The study plans to enroll about 210 patients to compare methylprednisolone sodium succinate with a placebo in this setting. Participants who have had successful recanalization after mechanical thrombectomy will be randomly assigned to receive either intra-arterial methylprednisolone sodium succinate 40 mg immediately after the procedure followed by intravenous methylprednisolone sodium succinate at 2 mgkg daily for three days, or placebo infusions of sterile water both intra-arterially and intravenously. The trial includes two groups and uses quadruple masking to maintain blinding of participants and study personnel. During the study, patients will be monitored for the incidence of symptomatic intracranial hemorrhage within 48 hours and mortality at 90 days as primary outcomes. Researchers will also assess shifts in disability scores using the modified Rankin Scale, rates of brain hemorrhage, pneumonia, gastrointestinal hemorrhage, serious adverse events, and quality of life measures over the follow-up period. The trial includes comprehensive imaging and clinical assessments, with safety and efficacy outcomes closely tracked for up to 90 days after treatment.

CONDITIONS

Brief Title

Intra-arterial Methylprednisolone After Endovascular Thrombectomy

Research Team

W

Wei Guo, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here